DAIVOBET

ABDI IBRAHIM OTSUKA
Identification
- Active ingredient (INN)
- CALCIPOTRIOL/BETAMETHASONE
- Internal code
- 07 S 189
- Country of Origin
- Algeria
- Pharmaceutical form
- Gel
- Prescription List
- Highly Regulated (List I)
- Packaging
- flacon de 60g

DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
Calcipotriol (INN) or calcipotriene (USAN) is a sythetic derivative of calcitriol or Vitamin D.
Indications
For the treatment of moderate plaque psoriasis in adults.
Pharmacodynamics
Calcipotriene is a synthetic analog of vitamin D. In humans, the natural supply of vitamin D depends mainly on exposure to the ultraviolet rays of the sun for conversion of 7-dehydrocholesterol to vitamin D3 (cholecalciferol) in the skin.
Absorption
Clinical studies with radiolabeled ointment indicate that approximately 6% (+3%, SD) of the applied dose of calcipotriene is absorbed systemically when the ointment is applied topically to psoriasis plaques or 5% (+2.6%, SO) when applied to normal skin.
Metabolism
Calcipotriene metabolism following systemic uptake is rapid, and occurs via a similar pathway to the natural hormone.
The primary metabolites are much less potent than the parent compound.
Route of Elimination
The active form of the vitamin, 1,25-dihydroxy vitamin D3 (calcitriol), is known to be recycled via the liver and excreted in the bile.
There is evidence that maternal 1,25-dihydroxy vitamin D3 (calcitriol) may enter the fetal circulation, but it is not known whether it is excreted in human milk.
Adverse Effects
Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.
Toxicity
Topically applied calcipotriene can be absorbed in sufficient amounts to produce systemic effects.
Elevated serum calcium has been observed with excessive use of calcipotriene.